EMA PHARMACEUTICAL NEWS IN BRIEFS
December 1st, 2012
BY KEITH NUTHALL
THE EUROPEAN Medicines Agency (EMA) has released s discussion paper on how current medicine shortages could be cause by manufacturing and good manufacturing practice compliance problems
*Meanwhile, the agency has published information on urgent procedures and related fees for issuing medicinal product certificates
*It has released comments received about guidance on establish a pharmacological acceptable daily intakes -
*EMA has also released guidance on pharmacovigilance inspections -
*And it has launched two public consultations on ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.